Skip to content
healthcare.dev

Auryxia

NDC 59922-631, ferric citrate, tablet, film coated, from Akebia Therapeutics, Inc..

Product NDC
59922-631
Status
Listed
Labeler
Akebia Therapeutics, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205874
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59922-631 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TETRAFERRIC TRICITRATE DECAHYDRATE210 mg/1

Pharmacologic classes

Iron [CS]; Parenteral Iron Replacement [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]

Package NDCNDC-11Package
59922-631-0159922063101200 TABLET, FILM COATED in 1 BOTTLE (59922-631-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/aadd18e0-3752-11e4-8510-0800200c9a66
  • NADAC price for package 59922063101

    GET /v1/drugs/nadac/59922063101

Use it

Look up 59922-631 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59922-631 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59922-631. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.